LBG Helps Advance Development of MCMs

Robert Casillas, Ph.D., Managing Director, and Sarah Herring, Ph.D., Consultant, are attending the 15th Annual CounterACT Network Research Symposium in New Orleans on June 21 – 23.

Dr. Casillas is a business strategic professional and biochemical toxicologist with more than 28 years of nonclinical development experience identifying workable solutions for novel products in the Medical Countermeasures (MCMs) and Companion Animal Health markets. His expertise includes 20 years managing CRO chem/bio containment and preclinical facilities, He provides a proven customer focus and value creation for global clients with demonstrated success in establishing strategic partnerships and cross-functional teams to develop new revenue streams and drive growth.

Dr, Casillas has worked with government-funded small/large pharma, virtual biotech, and academia, as well as the top small/large global animal health companies, the DoD (e.g., DTRA, JPEO, DARPA), DHHS (e.g., BARDA, NIH, FDA, CDC), and DoE to develop national defense, public/animal health MCMs.

LGB is pleased to be one of the sponsors of the event, presented by the University of Alabama at Birmingham, which “[brings] together chemists, toxicologists, drug developers, pharmacists, clinicians, and public health researchers.”